Skip to content

A Pilot Study on Efficacy of Transconjunctival Dexamethasone in treatment of upper lid retraction in thyroid eye disease

A Pilot Study on Efficacy of Transconjunctival Dexamethasone in treatment of upper lid retraction in thyroid eye disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240703001
Enrollment
20
Registered
2024-07-03
Start date
2024-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Efficacy of Transconjunctival Dexamethasone in treatment of upper lid retraction in thyroid eye disease transconjunctival dexamethasone lid retraction thyroid eye disease

Interventions

Transconjunctival Dexamethasone in treatment of upper lid retraction in thyroid eye disease
Treatment
Dexamethasone

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Over 18 years old. 2. Patients with thyroid retinopathy have a upper lid retraction less than 1 year, the distance from the center of cornea to the upper eyelid (margin reflex distance1) more than 5 millimeters. 3. Thyroid hormone levels Free T3 and/or Free T4 were within normal at least 3 months before participating in this study. 4. Not smoke or if smoked must abstain more than 6 months before participating in this study.

Exclusion criteria

Exclusion criteria: 1. Have eyelid surgery in the past 6 months before or plan to surgery during participate in this study. 2. Have eye orbital surgery in the past 6 months before or plan to surgery during participate in this study. 3. Have receive treatment with triamcinolone or dexamethasone injection in eyelid before. 4. Have received treatment with other eyelid injections in the past 6 months before. 5. Intra ocular pressure more than 21 mmHg or visual field abnormality or any glaucoma suspect. 6. Smoked in during this study. 7. Have eyelid infection.

Design outcomes

Primary

MeasureTime frame
margin reflex distance 1 (MRD1) at first visit, 1 month, 2 month, 3 month, 6 month, 9 month decrease margin reflex distance more than 1 millimeter or normal upper eyelid position

Secondary

MeasureTime frame
eyelid edema, eyelid injection, chemosis, conjunctival injection at first visit, 1 month, 2 month, 3 month, 6 month, 9 month Slit lamp microscope examination,Clinical activity score (CAS), Graves ophthalmopathy quality of life (GO-QOL) Thai version at first visit, 1 month, 2 month, 3 month, 6 month, 9 month Questionaire test

Countries

Thailand

Contacts

Public ContactPimkwan Jaruampornpan

Faculty of Medicine Siriraj Hospital

pimkwanj@gmail.com0944199164

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026